Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.78 is 52% below its 5-year average of 1.65, near the low end of its 5-year range (0.22–8.69).
As of the fiscal period ended Wednesday, December 31, 2025. 31.22% below its 12-month average of 1.14.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 0.78.
QUICK RATIO (ACID-TEST)
0.78
QUICK RATIO (ACID-TEST) AVG TTM
1.14
QUICK RATIO (ACID-TEST) AVG 3Y
1.09
QUICK RATIO (ACID-TEST) AVG 5Y
1.65
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-31.22%
CURRENT VS 3Y AVG
-28.06%
CURRENT VS 5Y AVG
-52.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-76.66%
vs the sector median at left
Niki BioSolutions, Inc.
Market Cap
$401484.00
Quick Ratio (Acid-Test)
0.78
TTM Avg
1.14
3Y Avg
1.09
5Y Avg
1.65
Market Cap
$356454.00
Quick Ratio (Acid-Test)
9.90
TTM Avg
8.52
3Y Avg
13.30
5Y Avg
8.87
Market Cap
$492926.00
Quick Ratio (Acid-Test)
3.59
TTM Avg
2.57
3Y Avg
4.32
5Y Avg
8.01
Market Cap
$527596.00
Quick Ratio (Acid-Test)
1.70
TTM Avg
2.81
3Y Avg
3.06
5Y Avg
14.47
Market Cap
$246973.00
Quick Ratio (Acid-Test)
2.38
TTM Avg
3.83
3Y Avg
3.05
5Y Avg
3.34
Market Cap
$566203.00
Quick Ratio (Acid-Test)
0.06
TTM Avg
0.15
3Y Avg
3.02
5Y Avg
6.94
Market Cap
$108771.00
Quick Ratio (Acid-Test)
0.94
TTM Avg
1.53
3Y Avg
2.70
5Y Avg
2.29
Market Cap
$695120.00
Quick Ratio (Acid-Test)
1.49
TTM Avg
0.81
3Y Avg
1.60
5Y Avg
1.33
Market Cap
$97282.00
Quick Ratio (Acid-Test)
8.09
TTM Avg
12.83
3Y Avg
6.46
5Y Avg
13.37
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niki BioSolutions, Inc. (NIKI) | $401484.00 | 0.78 | 1.14 | 1.09 | 1.65 |
| Virax Biolabs Group Limited (VRAX)vs › | $356454.00 | 9.90 | 8.52 | 13.30 | 8.87 |
| XORTX Therapeutics Inc. (XRTX)vs › | $492926.00 | 3.59 | 2.57 | 4.32 | 8.01 |
| VivoSim Labs, Inc. (VIVS)vs › | $527596.00 | 1.70 | 2.81 | 3.06 | 14.47 |
| SciSparc Ltd. (SPRC)vs › | $246973.00 | 2.38 | 3.83 | 3.05 | 3.34 |
| HCW Biologics Inc. (HCWB)vs › | $566203.00 | 0.06 | 0.15 | 3.02 | 6.94 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108771.00 | 0.94 | 1.53 | 2.70 | 2.29 |
| CDT Equity Inc. (CDT)vs › | $695120.00 | 1.49 | 0.81 | 1.60 | 1.33 |
| Psyence Biomedical Ltd. (PBM)vs › | $97282.00 | 8.09 | 12.83 | 6.46 | 13.37 |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $726206.00 | 7.25 | 5.33 | 3.37 | 2.65 |
Quick Ratio
0.78
Excludes inventory
Current Ratio
0.78
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 0.78 |
| 2025-09-30 | 0.56 |
| 2025-06-30 | 2.98 |
| 2024-12-31 | 0.22 |
| 2024-06-30 | 1.17 |
| 2023-12-31 | 1.18 |
| 2023-06-30 | 1.24 |
| 2022-12-31 | 0.56 |
| 2022-06-30 | 1.13 |
| 2021-12-31 | 2.89 |
| 2021-06-30 | 5.39 |
| 2020-12-31 | 8.69 |
| 2020-06-30 | 1.98 |
| 2019-12-31 | 2.99 |
| 2019-06-30 | 12.91 |
| 2018-12-31 | 2.35 |
| 2018-06-30 | 1.57 |
